Cargando…
D2-40 A Helpful Marker in Assessment of Lymphatic Vessel Invasion in Carcinoma of Breast
BACKGROUND & OBJECTIVE: Breast cancer is the most common malignancy among Iranian women and worldwide. Lymphatic vessel invasion (LVI) was found to be an independent prognostic factor in many carcinomas, including invasive carcinoma of the breast. The aim of this study was to compare the hematox...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Society of Pathology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085290/ https://www.ncbi.nlm.nih.gov/pubmed/33936219 http://dx.doi.org/10.30699/IJP.2020.114511.2245 |
_version_ | 1783686305439285248 |
---|---|
author | Vosough, Zeinab Golbini, Shima Sharbatdaran, Majid Hosseini, Akramossadat |
author_facet | Vosough, Zeinab Golbini, Shima Sharbatdaran, Majid Hosseini, Akramossadat |
author_sort | Vosough, Zeinab |
collection | PubMed |
description | BACKGROUND & OBJECTIVE: Breast cancer is the most common malignancy among Iranian women and worldwide. Lymphatic vessel invasion (LVI) was found to be an independent prognostic factor in many carcinomas, including invasive carcinoma of the breast. The aim of this study was to compare the hematoxylin and eosin (H&E) staining method and use of the immunohistochemical (IHC) marker ofD2-40, for evaluation of LVI in breast carcinoma specimens. METHODS: The study was conducted on 50 patients undergone surgery between the years 2010 and 2015 in Rohani Hospital, Babol, Iran with invasive carcinoma of the breast with Census sampling method. LVI was assessed by two surgical pathologists, using H&E- stained sections and two IHC markers, i.e., D2-40 and CD31. RESULTS: LVI was detected in 25 (50%) patients by H&E and in 14 (28%) patients by D2-40. Twelve out of 25 patients with positive LVI in H&E were confirmed by D2-40 and 2 out of 25 patients with negative lymphatic vessel in H&E. Only one case showed weak staining of CD31 proving LVI. These results showed a significant difference between the H&E staining and D2-40 IHC study for LVI detection (P=0.004). CONCLUSION: The D2-40 IHC marker is helpful in the diagnosis and confirmation of LVI in invasive carcinoma of the breast. CD31 is not suitable for the evaluation of lymphatic vessels. |
format | Online Article Text |
id | pubmed-8085290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Iranian Society of Pathology |
record_format | MEDLINE/PubMed |
spelling | pubmed-80852902021-04-30 D2-40 A Helpful Marker in Assessment of Lymphatic Vessel Invasion in Carcinoma of Breast Vosough, Zeinab Golbini, Shima Sharbatdaran, Majid Hosseini, Akramossadat Iran J Pathol Original Article BACKGROUND & OBJECTIVE: Breast cancer is the most common malignancy among Iranian women and worldwide. Lymphatic vessel invasion (LVI) was found to be an independent prognostic factor in many carcinomas, including invasive carcinoma of the breast. The aim of this study was to compare the hematoxylin and eosin (H&E) staining method and use of the immunohistochemical (IHC) marker ofD2-40, for evaluation of LVI in breast carcinoma specimens. METHODS: The study was conducted on 50 patients undergone surgery between the years 2010 and 2015 in Rohani Hospital, Babol, Iran with invasive carcinoma of the breast with Census sampling method. LVI was assessed by two surgical pathologists, using H&E- stained sections and two IHC markers, i.e., D2-40 and CD31. RESULTS: LVI was detected in 25 (50%) patients by H&E and in 14 (28%) patients by D2-40. Twelve out of 25 patients with positive LVI in H&E were confirmed by D2-40 and 2 out of 25 patients with negative lymphatic vessel in H&E. Only one case showed weak staining of CD31 proving LVI. These results showed a significant difference between the H&E staining and D2-40 IHC study for LVI detection (P=0.004). CONCLUSION: The D2-40 IHC marker is helpful in the diagnosis and confirmation of LVI in invasive carcinoma of the breast. CD31 is not suitable for the evaluation of lymphatic vessels. Iranian Society of Pathology 2021 2020-12-20 /pmc/articles/PMC8085290/ /pubmed/33936219 http://dx.doi.org/10.30699/IJP.2020.114511.2245 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution- 4.0 International License, (https://creativecommons.org/licenses/by/4.0/) which permits Share, copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, even commercially |
spellingShingle | Original Article Vosough, Zeinab Golbini, Shima Sharbatdaran, Majid Hosseini, Akramossadat D2-40 A Helpful Marker in Assessment of Lymphatic Vessel Invasion in Carcinoma of Breast |
title | D2-40 A Helpful Marker in Assessment of Lymphatic Vessel Invasion in Carcinoma of Breast |
title_full | D2-40 A Helpful Marker in Assessment of Lymphatic Vessel Invasion in Carcinoma of Breast |
title_fullStr | D2-40 A Helpful Marker in Assessment of Lymphatic Vessel Invasion in Carcinoma of Breast |
title_full_unstemmed | D2-40 A Helpful Marker in Assessment of Lymphatic Vessel Invasion in Carcinoma of Breast |
title_short | D2-40 A Helpful Marker in Assessment of Lymphatic Vessel Invasion in Carcinoma of Breast |
title_sort | d2-40 a helpful marker in assessment of lymphatic vessel invasion in carcinoma of breast |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085290/ https://www.ncbi.nlm.nih.gov/pubmed/33936219 http://dx.doi.org/10.30699/IJP.2020.114511.2245 |
work_keys_str_mv | AT vosoughzeinab d240ahelpfulmarkerinassessmentoflymphaticvesselinvasionincarcinomaofbreast AT golbinishima d240ahelpfulmarkerinassessmentoflymphaticvesselinvasionincarcinomaofbreast AT sharbatdaranmajid d240ahelpfulmarkerinassessmentoflymphaticvesselinvasionincarcinomaofbreast AT hosseiniakramossadat d240ahelpfulmarkerinassessmentoflymphaticvesselinvasionincarcinomaofbreast |